BEKSAÇ, M. Et Al. 2022. Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19). 64th ASH Annual Meeting & Exposition , (United States Of America).

BEKSAÇ, M., TUĞLULAR, A. T., GAY, F., MİNA, R., Katodritou, E., ÜNAL, A., ... Cavo, M.(2022). Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19) . 64th ASH Annual Meeting & Exposition, United States Of America

BEKSAÇ, MERAL Et Al. "Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)," 64th ASH Annual Meeting & Exposition, United States Of America, 2022

BEKSAÇ, MERAL Et Al. "Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)." 64th ASH Annual Meeting & Exposition , United States Of America, 2022

BEKSAÇ, M. Et Al. (2022) . "Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)." 64th ASH Annual Meeting & Exposition , United States Of America.

@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)}, congress name={64th ASH Annual Meeting & Exposition}, city={}, country={United States Of America}, year={2022}}